High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

Influenza vaccination can be less effective in patients treated with immunosuppressive therapy. However, little is known about the effects of ustekinumab; an anti-IL-12/23 agent used to treat Crohn’s disease (CD), on vaccination response. In this prospective study, we assessed immune responses to se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccines (Basel)
Hauptverfasser: Doornekamp, Laura, Goetgebuer, Rogier L., Schmitz, Katharina S., Goeijenbier, Marco, van der Woude, C. Janneke, Fouchier, Ron, van Gorp, Eric C.M., de Vries, Annemarie C.
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565576/
https://ncbi.nlm.nih.gov/pubmed/32824111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030455
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge